Jan 11, 2019
The commercialization of IT: transforming from cost center to revenue stream
At this time, the trend toward as-a-service consumption continues to grow. In a world where mixtures of on-prem as well as public and private cloud systems and applications make up the IT infrastructure, traditional operating models are unable to...
Dec 20, 2018
To Create Successful Adherence Programs, Know Your Patients
Today’s most successful adherence programs are no longer one-way communications solely about the product. Rather, they employ a more holistic approach that encourages patient interaction.
Dec 20, 2018
Patient Engagement Keys to Success: Focus on the Patient
Every patient is unique and every patient’s journey is unique. That’s why it’s important to allow the patient to drive the topics and the cadence of the engagement based on what’s happening in that patient’s journey at that particular time...
Dec 20, 2018
Medical Monitoring 101: Providing Medical Expertise for Clinical Trials
Medical monitoring is an essential component of the clinical research process. Medical monitors provide medical expertise and oversight for the entire clinical trial, from initial study design through final study close-out. They ensure the clinical...
Dec 20, 2018
Going 75 miles an hour… Or when management wants to take risks with drug safety
Recently I had an interesting question posed to me. Someone asked me to help explain to management at his company what happens when the drug safety (DS)/pharmacovigilance (PV) group does not do a good job! Management wanted to know why they needed...
Dec 20, 2018
Explaining Drug Safety & PV to Senior Management… and Your Mom!
In the course of many years in pharma heading drug safety groups and now consulting, training and doing outreach to the public, I continue to be amazed and humbled by the lack of knowledge by the public about drug safety and what those little pills...
Dec 19, 2018
Drug Safety and AEs in Children
As the saying goes, children are not small adults. Children differ markedly from adults in terms of biology and physiology. In particular, how they handle drugs is quite different. Thus the approach of pharmacovigilance to SAEs and AEs in children...
Dec 19, 2018
Adopting Patient Centricity at Scale: Creating Synergy for Program Success
While the pharmaceutical industry has been incorporating patient-centered practices within engagement and adherence programs for quite some time, the truth is that functional silos limit the ability for companies to fully adopt patient centricity at...
Pages
Jan 11, 2019
The commercialization of IT: transforming from cost center to revenue stream
At this time, the trend toward as-a-service consumption continues to grow. In a world where mixtures of on-prem as well as public and private cloud systems and applications make up the IT infrastructure, traditional operating models are unable to...
Sep 07, 2018
HCL and Cisco: Blazing the Trail in Consumption Offering
The demand for public and enterprise level private cloud with flexible consumption model continues to grow. This shift in consumption is manifesting itself in everything from simple process changes to industry disrupting inventions. HCL and Cisco...
Jun 05, 2018
A Network Automation Dynamic Duo: NetBrain & NetBOT by HCL Technologies
NetBrain & HCL's NetBOT are a Network Automation Dynamic Duo.NetBrain delivers network visibility and automation, while NetBOT makes networks proactive and self-aware. Read the blog to know some of the use cases on how they work...
Oct 26, 2018
How SD-WAN Enables Digital IT Transformation
SD-WAN can enable enterprises to accelerate the migration from a legacy network architecture to a new business-first networking model that optimizes the WAN more effectively and economically while ensuring high throughput, performance, availability...Dec 20, 2018
Patient Engagement Keys to Success: Focus on the Patient
Every patient is unique and every patient’s journey is unique. That’s why it’s important to allow the patient to drive the topics and the cadence of the engagement based on what’s happening in that patient’s journey at that particular time...Dec 20, 2018
Going 75 miles an hour… Or when management wants to take risks with drug safety
Recently I had an interesting question posed to me. Someone asked me to help explain to management at his company what happens when the drug safety (DS)/pharmacovigilance (PV) group does not do a good job! Management wanted to know why they needed...Dec 20, 2018
Explaining Drug Safety & PV to Senior Management… and Your Mom!
In the course of many years in pharma heading drug safety groups and now consulting, training and doing outreach to the public, I continue to be amazed and humbled by the lack of knowledge by the public about drug safety and what those little pills...
Aug 01, 2017
Gender Equality: Why Leadership Matters
Several subconscious or unconscious biases while decision making leads to gender inequality at work places. If top leadership takes necessary steps then this inequality can be a thing of the past. The organization has to enable them to accommodate...